Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Matrix Biol ; 83: 6-25, 2019 10.
Artículo en Inglés | MEDLINE | ID: mdl-31220558

RESUMEN

Osteoporosis is the most common degenerative bone disease that occurs when the balance of bone production and resorption is perturbed. Loss of bone mass or alteration in its quality leads to significant weakening of the bones and subsequently to higher fracture risk. Collagen XIII (ColXIII) is a conserved transmembrane protein expressed in many mesenchymal tissues. Here we show that ColXIII is a regulator of bone remodeling niche. In this study, we found that ColXIII expression is significantly upregulated in osteoporotic patients. In view of that, we studied bone homeostasis in ColXIII-overexpressing mice (Col13a1oe) up to 72 weeks of age and observed a cortical bone overgrowth followed by a drastic bone loss, together with increased bone vascularization. Moreover, our results demonstrate that the ColXIII-derived ectodomain enhances angiogenesis through ß1-integrins and the JNK pathway. Consequently, these data suggest that ColXIII has a role in age-dependent cortical bone deterioration with possible implications for osteoporosis and fracture risk.


Asunto(s)
Colágeno Tipo XIII/genética , Colágeno Tipo XIII/metabolismo , Osteoblastos/citología , Osteoporosis/metabolismo , Regulación hacia Arriba , Animales , Células Cultivadas , Colágeno Tipo XIII/química , Modelos Animales de Enfermedad , Humanos , Integrina beta1/metabolismo , Sistema de Señalización de MAP Quinasas , Ratones , Ratones Transgénicos , Osteoblastos/metabolismo , Osteogénesis , Dominios Proteicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA